The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome-Lysosome Fusion

Lin Ai; Hangui Ren; Yuan Wang; Mengfan Liu; Yufei Qiu; Jiling Feng; Rongchen Dai; Wang Fu; Yongpeng Wang; Zhichao Xi; Hongxi Xu; Feng Wang

doi:10.1111/cpr.70071

Cell Proliferation ›› 2026, Vol. 59 ›› Issue (1) :e70071 DOI: 10.1111/cpr.70071

ORIGINAL ARTICLE

The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome-Lysosome Fusion

Author information +

History +

PDF

Abstract

Ginsenoside Rg1 has shown promise in ameliorating cerebral ischemia–reperfusion injury (CIRI). However, its precise molecular mechanisms remain unclear. In this study, an in vitro CIRI model was established using SH-SY5Y and SK-N-AS neuronal cell lines subjected to oxygen–glucose deprivation followed by reoxygenation (OGD/R). For the in vivo model, C57BL/6J mice underwent middle cerebral artery occlusion and subsequent reperfusion (MCAO/R). The protective effects of Rg1 against OGD/R injury were analysed using the CCK-8 assay and the PI exclusion method. The in vivo neuroprotective effects of Rg1 against CIRI were evaluated using various assessments, including brain blood flow, neurological deficits, behavioural tests, TTC, H&E, Nissl and TUNEL staining. Mitophagy was assessed by detecting mitophagy-initiating proteins via Western blotting, transmission electron microscopy, immunohistochemistry and immunofluorescence staining. Additionally, mitochondrial function was assessed by ATP measurement, the JC-1 assay and MitoSOX-based flow cytometry. Our results show that Rg1 significantly mitigated cell death caused by OGD/R and substantially enhanced cell viability in vitro. Moreover, Rg1 alleviated OGD/R-induced mitochondrial dysfunction, as indicated by preserved mitochondrial membrane potential and decreased mitochondrial ROS levels. Mitophagy was induced after OGD treatment, which was subsequently inhibited by Rg1 during reperfusion. Mechanistically, Rg1 disrupted the fusion of mitophagosomes with lysosomes rather than inhibiting mitophagy initiation, leading to an accumulation of mitochondrial proteins and mitophagy-initiating proteins. Notably, prolonged inhibition of mitophagy by Rg1 did not induce cytotoxicity or exacerbate mitochondrial dysfunction. Furthermore, administration of Rg1 in MCAO/R mice significantly improved brain blood reperfusion, reduced infarct volume, improved neurological deficits, preserved brain tissue integrity and decreased neuronal apoptosis. Consistent with the in vitro observations, Rg1 upregulated mitophagy-related protein expression in MCAO/R mouse brain tissues, indicating potential inhibition of mitophagy. In conclusion, our study reveals that Rg1 significantly alleviates CIRI at least partially by suppressing mitophagy, specifically by impeding the fusion of mitophagosomes with lysosomes.

Keywords

cerebral ischemia–reperfusion injury / ginsenoside Rg1 / ischemic stroke / mitophagosome-lysosome fusion / mitophagy

Cite this article

Download citation ▾

Lin Ai, Hangui Ren, Yuan Wang, Mengfan Liu, Yufei Qiu, Jiling Feng, Rongchen Dai, Wang Fu, Yongpeng Wang, Zhichao Xi, Hongxi Xu, Feng Wang. The Neuroprotective Role of Ginsenoside Rg1 Against Cerebral Ischemia–Reperfusion Damage Through Inhibition of Mitophagy via Blocking Mitophagosome-Lysosome Fusion. Cell Proliferation, 2026, 59(1): e70071 DOI:10.1111/cpr.70071

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	M. Zhang, Q. Liu, H. Meng, et al., “Ischemia-Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 12.

[2]	M. Lu, F. Zhao, C. Ran, Y. Xu, J. Zhang, and H. Wang, “Ginsenoside Rg1 Attenuates Diabetic Vascular Endothelial Dysfunction by Inhibiting the Calpain-1/ROS/PKC-β Axis,” Life Sciences 329 (2023): 121972.

[3]	S. J. Yang, J. J. Wang, P. Cheng, L. X. Chen, J. M. Hu, and G. Q. Zhu, “Ginsenoside Rg1 in Neurological Diseases: From Bench to Bedside,” Acta Pharmacologica Sinica 44, no. 5 (2023): 913–930.

[4]	L. Wang, H. Zhao, Z. Z. Zhai, and L. X. Qu, “Protective Effect and Mechanism of Ginsenoside Rg1 in Cerebral Ischaemia-Reperfusion Injury in Mice,” Biomedicine & Pharmacotherapy 99 (2018): 876–882.

[5]	T. Zheng, H. Jiang, R. Jin, et al., “Ginsenoside Rg1 Attenuates Protein Aggregation and Inflammatory Response Following Cerebral Ischemia and Reperfusion Injury,” European Journal of Pharmacology 853 (2019): 65–73.

[6]	S. F. Chu, Z. Zhang, X. Zhou, et al., “Ginsenoside Rg1 Protects Against Ischemic/Reperfusion-Induced Neuronal Injury Through miR-144/Nrf2/ARE Pathway,” Acta Pharmacologica Sinica 40, no. 1 (2019): 13–25.

[7]	J. Long, Y. Sun, S. Liu, et al., “Ginsenoside Rg1 Treats Ischemic Stroke by Regulating CKLF1/CCR5 Axis-Induced Neuronal Cell Pyroptosis,” Phytomedicine 123 (2024): 155238.

[8]	Z. C. Xi, H. G. Ren, L. Ai, et al., “Ginsenoside Rg1 Mitigates Cerebral Ischaemia/Reperfusion Injury in Mice by Inhibiting Autophagy Through Activation of mTOR Signalling,” Acta Pharmacologica Sinica 45, no. 12 (2024): 2474–2486.

[9]	S. Kumar Saini and D. Singh, “Mitochondrial Mechanisms in Cerebral Ischemia-Reperfusion Injury: Unravelling the Intricacies,” Mitochondrion 77 (2024): 101883.

[10]	J. Huang, L. Chen, Z. M. Yao, X. R. Sun, X. H. Tong, and S. Y. Dong, “The Role of Mitochondrial Dynamics in Cerebral Ischemia-Reperfusion Injury,” Biomedicine & Pharmacotherapy 162 (2023): 114671.

[11]	Y. Hu, H. Deng, S. Xu, and J. Zhang, “MicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion Injury,” International Journal of Molecular Sciences 16, no. 10 (2015): 24895–24917.

[12]	P. Terešak, A. Lapao, N. Subic, P. Boya, Z. Elazar, and A. Simonsen, “Regulation of PRKN-Independent Mitophagy,” Autophagy 18, no. 1 (2022): 24–39.

[13]	J. Zhang and P. A. Ney, “Role of BNIP3 and NIX in Cell Death, Autophagy, and Mitophagy,” Cell Death and Differentiation 16, no. 7 (2009): 939–946.

[14]	M. Lazarou, D. A. Sliter, L. A. Kane, et al., “The Ubiquitin Kinase PINK1 Recruits Autophagy Receptors to Induce Mitophagy,” Nature 524, no. 7565 (2015): 309–314.

[15]	A. Ajoolabady, H. Aslkhodapasandhokmabad, A. Aghanejad, Y. Zhang, and J. Ren, “Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing,” Ageing Research Reviews 62 (2020): 101129.

[16]	Q. Cai and Y. Y. Jeong, “Mitophagy in Alzheimer's Disease and Other Age-Related Neurodegenerative Diseases,” Cells 9, no. 1 (2020): 150.

[17]	Y. Zhang, Y. He, M. Wu, et al., “Rehmapicroside Ameliorates Cerebral Ischemia-Reperfusion Injury via Attenuating Peroxynitrite-Mediated Mitophagy Activation,” Free Radical Biology & Medicine 160 (2020): 526–539.

[18]	A. D. Chapp, J. E. Behnke, K. M. Driscoll, et al., “Acetate Mediates Alcohol Excitotoxicity in Dopaminergic-Like PC12 Cells,” ACS Chemical Neuroscience 10, no. 1 (2019): 235–245.

[19]	X. Q. Xie, Y. Yang, Q. Wang, et al., “Targeting ATAD3A-PINK1-Mitophagy Axis Overcomes Chemoimmunotherapy Resistance by Redirecting PD-L1 to Mitochondria,” Cell Research 33, no. 3 (2023): 215–228.

[20]	Y. Y. Sun, H. J. Zhu, R. Y. Zhao, et al., “Remote Ischemic Conditioning Attenuates Oxidative Stress and Inflammation via the Nrf2/HO-1 Pathway in MCAO Mice,” Redox Biology 66 (2023): 102852.

[21]	J. M. Wider, E. Gruley, P. T. Morse, et al., “Modulation of Mitochondrial Function With Near-Infrared Light Reduces Brain Injury in a Translational Model of Cardiac Arrest,” Critical Care 27, no. 1 (2023): 491.

[22]	H. Katayama, H. Hama, K. Nagasawa, et al., “Visualizing and Modulating Mitophagy for Therapeutic Studies of Neurodegeneration,” Cell 181, no. 5 (2020): 1176–1187.e16.

[23]	S. Fan, K. Wu, M. Zhao, et al., “LDHB Inhibition Induces Mitophagy and Facilitates the Progression of CSFV Infection,” Autophagy 17, no. 9 (2021): 2305–2324.

[24]	Y. Zheng, C. Huang, L. Lu, et al., “STOML2 Potentiates Metastasis of Hepatocellular Carcinoma by Promoting PINK1-Mediated Mitophagy and Regulates Sensitivity to Lenvatinib,” Journal of Hematology & Oncology 14, no. 1 (2021): 16.

[25]	A. H. Rezaeian, W. Wei, and H. Inuzuka, “Regulation of Neuronal Autophagy and Cell Survival by MCL1 in Alzheimer's Disease,” Acta Materia Medica 1, no. 1 (2022): 42–55.

[26]	M. A. Lampert, A. M. Orogo, R. H. Najor, et al., “BNIP3L/NIX and FUNDC1-Mediated Mitophagy Is Required for Mitochondrial Network Remodeling During Cardiac Progenitor Cell Differentiation,” Autophagy 15, no. 7 (2019): 1182–1198.

[27]	L. Shen, Q. Gan, Y. Yang, et al., “Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury,” Frontiers in Aging Neuroscience 13 (2021): 687246.

[28]	N. Wang, J. Yang, R. Chen, et al., “Ginsenoside Rg1 Ameliorates Alzheimer's Disease Pathology via Restoring Mitophagy,” Journal of Ginseng Research 47, no. 3 (2023): 448–457.

[29]	Z. Xu, C. Li, Q. Liu, H. Yang, and P. Li, “Ginsenoside Rg1 Protects H9c2 Cells Against Nutritional Stress-Induced Injury via Aldolase /AMPK/PINK1 Signalling,” Journal of Cellular Biochemistry 120, no. 10 (2019): 18388–18397.

[30]	M. A. Eldeeb, R. A. Thomas, M. A. Ragheb, A. Fallahi, and E. A. Fon, “Mitochondrial Quality Control in Health and in Parkinson's Disease,” Physiological Reviews 102, no. 4 (2022): 1721–1755.

[31]	X. Wu, Y. Zheng, M. Liu, et al., “BNIP3L/NIX Degradation Leads to Mitophagy Deficiency in Ischemic Brains,” Autophagy 17, no. 8 (2021): 1934–1946.

[32]	Y. Cai, E. Yang, X. Yao, et al., “FUNDC1-Dependent Mitophagy Induced by tPA Protects Neurons Against Cerebral Ischemia-Reperfusion Injury,” Redox Biology 38 (2021): 101792.

[33]	M. Wu, G. Lu, Y. Z. Lao, et al., “Garciesculenxanthone B Induces PINK1-Parkin-Mediated Mitophagy and Prevents Ischemia-Reperfusion Brain Injury in Mice,” Acta Pharmacologica Sinica 42, no. 2 (2021): 199–208.

[34]	H. Xian, Q. Yang, L. Xiao, H. M. Shen, and Y. C. Liou, “STX17 Dynamically Regulated by Fis1 Induces Mitophagy via Hierarchical Macroautophagic Mechanism,” Nature Communications 10, no. 1 (2019): 2059.

[35]	X. N. Li, N. Y. Shang, Y. Y. Kang, et al., “Caffeic Acid Alleviates Cerebral Ischemic Injury in Rats by Resisting Ferroptosis via Nrf2 Signaling Pathway,” Acta Pharmacologica Sinica 45, no. 2 (2024): 248–267.

[36]	T. Zhu, S. Dong, N. Qin, R. Liu, L. Shi, and Q. Wan, “Dl-3-n-Butylphthalide Attenuates Cerebral Ischemia/Reperfusion Injury in Mice Through AMPK-Mediated Mitochondrial Fusion,” Frontiers in Pharmacology 15 (2024): 1357953.

[37]	Y. Han, X. Li, L. Yang, et al., “Ginsenoside Rg1 Attenuates Cerebral Ischemia-Reperfusion Injury due to Inhibition of NOX2-Mediated Calcium Homeostasis Dysregulation in Mice,” Journal of Ginseng Research 46, no. 4 (2022): 515–525.

[38]	T. Zheng, H. Jiang, R. Jin, et al., “Ginsenoside Rg1 Attenuates Protein Aggregation and Inflammatory Response Following Cerebral Ischemia and Reperfusion Injury,” European Journal of Pharmacology 853 (2019): 65–73.

[39]	S. F. Chu, Z. Zhang, X. Zhou, et al., “Ginsenoside Rg1 Protects Against Ischemic/Reperfusion-Induced Neuronal Injury Through miR-144/Nrf2/ARE Pathway,” Acta Pharmacologica Sinica 40, no. 1 (2019): 13–25.

[40]	Y. Gu, K. Ren, L. Wang, C. Jiang, and Q. Yao, “Rg1 in Combination With Mannitol Protects Neurons Against Glutamate-Induced ER Stress via the PERK-eIF2 aAlpha-ATF4 Signaling Pathway,” Life Sciences 263 (2020): 118559.